<DOC>
	<DOCNO>NCT02615418</DOCNO>
	<brief_summary>This trial design preliminary evaluate efficacy safety NIBS system treatment chronic low back pain ( CLBP ) ( 6 month ) . The trial double blind sham control partial crossover design involve 2 weekly treatment evaluation 6 week , 6 week follow-up . The goal study 1 . Asses CLBP change immediate long term effect trial duration follow-up . 2 . Asses quality life improvement measure sleep quality questioner . 3 . Asses long term neuronal change lack thereof treat untreated subject .</brief_summary>
	<brief_title>Non Invasive Brain Stimulation Treatment CLBP</brief_title>
	<detailed_description />
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<criteria>Age 18 80 CLBP define European guideline . low back pain first week average NPRS &gt; 4 . 1 . Acute low back pain ( duration le 6 month ) first week average NPRS &gt; 4 2 . Neurological illness cause structural brain damage ( e.g . Stroke , TIA ) 3 . Psychiatric disease mood disorder 4 . Current chronic use medication proepileptic property 5 . Known alcohol dependency 6 . Use alcohol within previous 24 hour 7 . History loss consciousness 8 . Epilepsy epilepsy first degree relative 9 . Medical implant 10 . Pregnancy 11 . Illicit drug use within previous month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>